Robert C. Stein

149 Tottenham Court Road, W1T 7DN
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The role of healthcare professionals' communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTs.

The role of healthcare professionals' communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTs.

Journal: Trials

Published: December 01, 2023

Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer.

Multistate Gene Cluster Switches Determine the Adaptive Mitochondrial and Metabolic Landscape of Breast Cancer.

Journal: Cancer research

Published: October 11, 2023

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.

Journal: NPJ breast cancer

Published: January 28, 2021

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.

Computational approaches to support comparative analysis of multiparametric tests: Modelling versus Training.

Journal: PloS one

Published: April 15, 2020

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.

Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 17, 2019

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.

Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.

Journal: Health technology assessment (Winchester, England)

Published: July 03, 2019

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 08, 2018

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation.

Journal: Journal of clinical epidemiology

Published: July 12, 2018

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.

Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework.

Journal: Trials

Published: May 16, 2017

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial.

Journal: The Lancet. Oncology

Published: February 08, 2017

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.

Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Published: July 01, 2016

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

Journal: Health technology assessment (Winchester, England)

Published: February 12, 2016

Showing 1-12 of 16

Last Updated: 09/26/2026